NFKB1 and Alzheimer disease: The mice injected intracerebroventricularly with streptozotocin (STZ) exhibited sporadic AD symptoms, activation of the NF-κB signaling pathway, and increased secretion of IL-1β, while the treatment of AuNPs significantly inhibited the pro-inflammatory response via the NF-κB pathway (Muller et al., 2017).